[The hypoglycemic syndrome in extra-pancreatic tumors (hypoglycemic extrapancreatic tumors: H.E.P.T.)].
D000328:Adult; D000368:Aged; D045930:Anabolic Agents / Q000378:metabolism; D050260:Carbohydrate Metabolism; D005260:Female; D005350:Fibroma / Q000150:complications; D005947:Glucose / Q000378:metabolism; D006393:Hemangiopericytoma / Q000150:complications; D006801:Humans; D007003:Hypoglycemia / Q000209:etiology*; D007328:Insulin / Q000378:metabolism; D007329:Insulin Antagonists; D008297:Male; D008637:Mesenchymoma / Q000150:complications; D008654:Mesothelioma / Q000150:complications; D008875:Middle Aged; D009369:Neoplasms / Q000150:complications* / Q000378:metabolism; D010235:Paraganglioma / Q000150:complications; D012509:Sarcoma / Q000150:complications
D045930:Anabolic Agents; D007328:Insulin; D007329:Insulin Antagonists; D005947:Glucose
La sindrome ipoglicemica in tumori extra-pancreatici (tumori extra-pancreatici ipoglicemizzanti: T.E.P.I.)